NCT03433183 2026-05-27SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath TumorsSarcoma Alliance for Research through CollaborationPhase 2 Completed21 enrolled 12 charts